Axonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System - read this article along with other careers information, tips and advice on BioSpace
Axonics, Inc. , a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the first patient. | September 9, 2022
08.09.2022 - Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the first patient implants in Canada with the Axonics F15, .